Transmedics Group Inc reports results for the quarter ended in June - Earnings Summary

TransMedics

03/08/2023 22:49

* Transmedics Group Inc  TMDX.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue rose 155.7% to $52.47 million from a year ago;
analysts
expected $42.42 million. 
    * Transmedics Group Inc's reported EPS for the quarter was a
loss
of 3 cents​.
    * The mean earnings estimate of analysts had risen by
about 11% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Transmedics Group Inc shares had risen by 4.9% this
quarter and
gained 42.7% so far this year.
    * The company reported a quarterly loss of $1 million.
    * Wall Street's median 12-month price target for Transmedics
Group
Inc is $92.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.13          -0.03          Beat
 Mar. 31 2023      -0.25          -0.08          Beat
 Dec. 31 2022      -0.30          -0.21          Beat
 Sep. 30 2022      -0.41          -0.25          Beat